 | Draft article not currently submitted for review.
This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window. To be accepted, a draft should:
It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it. This draft has not been edited in over six months and qualifies to be deleted per CSD G13.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Last edited by Qwerfjkl (bot) (talk | contribs) 9 months ago. (Update) |
Harry Destecroix | |
|---|---|
| Born | 10 April 1987 |
| Occupation(s) | Entrepreneur, Investor, Scientist |
Dr. Harry Destecroix (born 10 April 1987) is a British scientist, entrepreneur, and investor, renowned for his support of university spinouts. In the midst of his doctoral research, he co-founded the biotech start-up Ziylo in 2014. A year later Harry founded Science Creates, an organisation supporting the formation of deep tech spinouts wanting to drive impact. By 2017, Harry and his team had completed construction of the first Science Creates deep tech incubator (formerly Unit DX). This was a critical moment in the growth of the UK’s Southwest deep tech cluster, inspiring local scientists and engineers to become entrepreneurs. In August 2018, under his leadership as CEO, Ziylo was acquired by Novo Nordisk in a deal worth up to $800 million for technology that creates smart insulin [1] [2].
Destecroix is also a co-founder of Carbometrics, a spinout from Ziylo, innovating in the glucose sensing arena for diabetes management.
Destecroix is a co-founder of the Science Creates Outreach charity. The charity was spun out in 2023 from STEM outreach programs that started alongside the opening of the first incubator[3]. Science Creates Outreach aims to spark a passion for deep tech entrepreneurship among schoolchildren, with 2500 next generation entrepreneurs trained to date.
Early Life and Education
- ^ Milne, Gemma. "Bristol Diabetes Spin-Out Acquired By Novo Nordisk For $800M". Forbes. Retrieved 2024-01-30.
- ^ Owens, Brian (2018-11-01). "Smart insulin: redesign could end hypoglycemia risk". Nature Biotechnology. 36 (10): 911–912. doi:10.1038/nbt1018-911a. ISSN 1546-1696.
- ^ Bristol, University of. "May: Unit DX anniversary | News and features | University of Bristol". www.bristol.ac.uk. Retrieved 2024-01-30.